161 related articles for article (PubMed ID: 16439542)
1. Novel Pol II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein.
Unwalla HJ; Li HT; Bahner I; Li MJ; Kohn D; Rossi JJ
J Virol; 2006 Feb; 80(4):1863-73. PubMed ID: 16439542
[TBL] [Abstract][Full Text] [Related]
2. Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells.
Harrison GS; Maxwell F; Long CJ; Rosen CA; Glode LM; Maxwell IH
Hum Gene Ther; 1991; 2(1):53-60. PubMed ID: 1863640
[TBL] [Abstract][Full Text] [Related]
3. Replication of HIV type 1 in rabbit cell lines is not limited by deficiencies in tat, rev, or long terminal repeat function.
Cho S; Kindt TJ; Zhao TM; Sawasdikosol S; Hague BF
AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1487-93. PubMed ID: 8679293
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus type 1 by Tat/Rev-regulated expression of cytosine deaminase, interferon alpha2, or diphtheria toxin compared with inhibition by transdominant Rev.
Ragheb JA; Couture L; Mullen C; Ridgway A; Morgan RA
Hum Gene Ther; 1999 Jan; 10(1):103-12. PubMed ID: 10022535
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
6. The HIV-1 transactivator protein Tat is a potent inducer of the human DNA repair enzyme beta-polymerase.
Srivastava DK; Tendler CL; Milani D; English MA; Licht JD; Wilson SH
AIDS; 2001 Mar; 15(4):433-40. PubMed ID: 11242139
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins.
Ulich C; Harrich D; Estes P; Gaynor RB
J Virol; 1996 Jul; 70(7):4871-6. PubMed ID: 8676525
[TBL] [Abstract][Full Text] [Related]
8. Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA.
Unwalla HJ; Li MJ; Kim JD; Li HT; Ehsani A; Alluin J; Rossi JJ
Nat Biotechnol; 2004 Dec; 22(12):1573-8. PubMed ID: 15568018
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIV-1 by a double transdominant fusion gene.
Aguilar-Cordova E; Chinen J; Donehower LA; Harper JW; Rice AP; Butel JS; Belmont JW
Gene Ther; 1995 May; 2(3):181-6. PubMed ID: 7614248
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene.
Harrison GS; Long CJ; Curiel TJ; Maxwell F; Maxwell IH
Hum Gene Ther; 1992 Oct; 3(5):461-9. PubMed ID: 1329991
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA.
Unwalla H; Banerjea AC
Biochem J; 2001 Jul; 357(Pt 1):147-55. PubMed ID: 11415445
[TBL] [Abstract][Full Text] [Related]
12. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
Natarajan V; Radjendirane V; Salzman NP
Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
[TBL] [Abstract][Full Text] [Related]
13. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
Southgate C; Zapp ML; Green MR
Nature; 1990 Jun; 345(6276):640-2. PubMed ID: 2190099
[TBL] [Abstract][Full Text] [Related]
14. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.
Ragheb JA; Bressler P; Daucher M; Chiang L; Chuah MK; VandenDriessche T; Morgan RA
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1343-53. PubMed ID: 8573391
[TBL] [Abstract][Full Text] [Related]
15. The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.
Liem SE; Ramezani A; Li X; Joshi S
Hum Gene Ther; 1993 Oct; 4(5):625-34. PubMed ID: 8280800
[TBL] [Abstract][Full Text] [Related]
16. RNA-sequence-mediated gene regulation in HIV-1.
Cullen BR
Infect Agents Dis; 1994; 3(2-3):68-76. PubMed ID: 7812657
[TBL] [Abstract][Full Text] [Related]
17. The tat gene and protein of the human immunodeficiency virus type 1.
Caputo A; Grossi MP; Rossi C; Campioni D; Balboni PG; Corallini A; Barbanti-Brodano G
New Microbiol; 1995 Jan; 18(1):87-110. PubMed ID: 7760763
[No Abstract] [Full Text] [Related]
18. Rev-dependent lentiviral expression vector.
Wu Y; Beddall MH; Marsh JW
Retrovirology; 2007 Feb; 4():12. PubMed ID: 17286866
[TBL] [Abstract][Full Text] [Related]
19. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
Peng H; Callison D; Li P; Burrell C
Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
[TBL] [Abstract][Full Text] [Related]
20. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
